EMV Capital
Venture capitalLondon · Pre-Seed–Series B · 19 people tracked
Also known as Greybridge It Limited · Netscientific Limited · Netscientific Plc
Find your way into EMV Capital
2,024 people in our graph share verified history with the EMV Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
EMV Capital focuses on generating strong investor returns by investing in early-stage companies operating in fast-growing sectors and technologies expected to shape the future. It targets businesses with attractive intellectual property and both high growth and impact potential. The firm applies a proactive, hands-on management style, working closely with companies over an extended period to advance them toward key value inflection points. Its capital-efficient model draws on its own balance sheet and syndicate investments. EMV concentrates on three areas: life sciences addressing healthcare system challenges, deeptech spanning industrials, robotics and AI, and sustainability including renewable energy, resource efficiency, waste reduction and sustainable supply chains.
Source: firm website, verified Aug 3, 2026.
Team · 19 people
from the firm's website & curated
What they invest in
from 56 of 61 portfolio companiesDeep Tech ×24Healthtech ×23Biotech ×18AI & Machine Learning ×17Hardware ×17Medical Devices ×13New Materials ×12Digital Health ×11
HQs:United Kingdom×37United States×5United Kingdom×1
Who they back
founder profiles across 23 portfolio companiesFounding team size:solo founder×142 founders×43 founders×5
Where their founders studiedfrom 24 founders with education data
University of Cambridge ×13Columbia Business School ×2Columbia Engineering ×2Imperial College London ×2Massachusetts Institute of Technology ×2
What their founders studiedfrom 24 founders with field-of-study data
Engineering ×13Physics ×5Business & Management ×4Computer Science ×3Life Sciences ×2Mathematics & Statistics ×2Medicine ×2
Where their founders worked beforefrom 25 founders with career history
SolidSpark ×2Spotta ×2Weizmann Institute of Science ×2
15 founders hold a PhD · 3 hold an MBA (of 24 with degree data)
Investments · 61 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12023 · 42022 · 12020 · 18 dated
PDS Biotech develops T cell activating immunotherapies for cancer and infectious disease vaccines in clinical stages.
BiotechHealthtechNorth Brunswick, US
Frank K. Bedu-Addo(Executive Officer)inFrank Bedu-Addo(President, Chief Executive Officer, Principal Executive Officer and Director)inGregory L. Conn(Chief Scientific Officer)Kirk Shepard(Chief Medical Officer)inLars Boesgaard(Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer)inStephan Toutain(Chief Operating Officer)in
Co-investorsElevate VenturesYorkville Advisors
A plastic chemical recycling company specializing in advanced recycling technology and plant operations for the circular economy sector.
Circular EconomyCleantechDeep TechNew MaterialsSwindon, GB
Marvine Besong(CEO)in
BoardSimon Ashby-Rudd(Chair)
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesIT-Farm Corporation+3 more
AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.
AI & Machine LearningBiotech
Peyman Gifani(Founder)in
Co-investorsDCVC (Data Collective)Manta Ray VenturesMartlet Capital
Allfocal Optics develops nanophotonic display technology based on research from Cambridge University, aimed at improving visual clarity and comfort.
Deep TechHardwareSemiconductorsCambridge, GB
Dr. Pawan Shrestha(Founder)in
Co-investors7percent VenturesMartlet CapitalCambridge Angels group
AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings.
BiotechHealthtechMedical Devices
AXOL is a biotech company backed by investors including Par Equity, Meltwind Advisory, and Scottish Enterprise.
BiotechDeep TechHealthtechRoslin, UK
Co-investorsCalculusScottish EnterpriseCambridge Angels groupMartlet Capital
Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.
CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB
Fabio Necco(CEO)in
Co-investorsCambridge Innovation CapitalIQ CapitalMartlet CapitalBritish Patient CapitalParkwalk Advisors
.jpeg){kind=logo}
Cambridge Nutraceuticals develops and sells health supplements grounded in clinical research and scientific evidence, serving consumers seeking science-backed nutritional products.
ConsumerHealthtechLongevityWellness & FitnessCambridge, GB
Co-investorsMartlet Capital
Camstent develops coated medical devices using proprietary bacteriophobic polymer technology to reduce biofilm formation and infection risk on silicon-based medical devices, particularly catheters.
BiotechHealthtechMedical DevicesNew MaterialsCambridge, GB
Co-investorsCambridge Angels groupMartlet Capital
CURE provides real-time monitoring of concrete curing, strength, and thermal performance using embedded and reusable sensors, paired with the ConcreteDNA app for tracking pours and AI-based curing predictions.
Advanced ManufacturingAI & Machine LearningConstruction TechIoTLondon, GB
Raph Scheps(CEO)inGideon Farrell(CTO)inRaphael Scheps(Founder)in
Co-investorsCambridge Angels groupClimate InvestmentEntrepreneur FirstJ-ImpactMartlet Capital
Deeptech Labs is a seed-stage venture capital firm and accelerator focused on deep technology companies founded with the University of Cambridge and industry partners including Arm and Cambridge Innovation Capital.
AI & Machine LearningDeep TechCambridge, GB
Miles Kirby(Chief Executive Officer)in
BoardEwan Kirk(Investor and Chair)
Co-investorsARMCambridge Innovation Capital
DName-it provides quality assurance for genetic testing by embedding molecular-level DNA identity markers into samples that travel through NGS-based workflows from collection to sequencing.
BiotechDeep TechHealthtech
Dogtooth Technologies develops autonomous robotic systems for agricultural harvesting, particularly strawberry picking.
AgTechAI & Machine LearningHardwareRoboticsCambridge, GB
Dr Duncan Robertson(Founder & CEO)Ed Herbert(Founder & COO)
Co-investors24 HaymarketMartlet Capital
Echion Technologies is a battery technology company that develops and commercialises XNO®, a niobium-based fast-charging battery anode material supplied to cell manufacturers worldwide.
CleantechDeep TechEnergyNew Materials
Jean de la Verpillière(CEO & Co-founder)inAlex Groombridge(CTO & Co-founder)inBen Ting(Chief Commercial Officer)inSarah Stevenson(Chief Operating Officer)inCeri Neal(Chief Financial Officer)in
Co-investorsKima VenturesMartlet CapitalZero Carbon CapitalVolta Energy Technologies
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardRobert Langer(Director)David Zhu(Director)in
Co-investorsBeresford VenturesHackensack Meridian Health Bear's DenKendall Capital PartnersPlum Alley InvestmentsTachyon VenturesTech Council Ventures
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)in
Co-investorsO2h VenturesWellcome TrustWren CapitalCambridge Angels groupMartlet CapitalStoic VC+1 more
FocalPoint develops positioning and navigation technology that improves accuracy beyond radio-based systems for everyday applications.
AI & Machine LearningDeep TechHardwareIoTMobility & TransportationUK, GB
Scott Pomerantz(CEO)in
Co-investorsMolten VenturesForte VenturesPassion CapitalCambridge Angels groupMartlet CapitalIQ Capital
Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer.
BiotechDigital HealthHealthtechMedical DevicesMerion Station, US
Charles Swindell(Executive Officer, Director)in
BoardIlian Iliev(Director)inEd Hooper(Director)inJenny Jiang(Director)
Co-investorsFosun Pharma
Mindler (previously ieso) provides one-to-one, therapist-delivered text-based cognitive behavioural therapy (CBT) delivered online to patients, using de-identified therapy data and analysis to inform treatment.
Digital HealthHealthtechMental Health
Co-investorsCambridge Angels groupMartlet CapitalMolten Ventures
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
AI & Machine LearningBiotechHealthtechMedical DevicesOxford, GB
Jonathan Kwok(Co-Founder, President & Chief Medical Officer)inLian Ni Lee(VP Preclinical & Co-Founder)in
Co-investorsAmplify PartnersManta Ray VenturesOctopus VenturesKindred CapitalMartlet Capital
Kalium Health is developing personalised, at-home health monitoring for chronic kidney disease, aimed at helping healthcare providers and patients track key risks to improve outcomes and reduce costs.
Digital HealthHealthtechMedical DevicesCambridge, GB
Fiona Karet(Chief Medical Officer)in
Co-investorsMartlet CapitalCambridge Angels group
VOLLO is an AI inference accelerator for capital markets firms that enables low-latency execution of machine learning models on market data using FPGA technology.
AI & Machine LearningCloud ComputingDeep TechFintechHardware
Peter(Founder)TomGiles
Co-investorsIQ CapitalMartlet CapitalNew Science Ventures
NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials.
AgTechBiotechHealthtechNew Materials
Co-investorsAdjuvoCambridge Angels groupMartlet CapitalThe FSE GroupThe Yield Lab EuropeACF Investors+1 more
Nu Quantum develops quantum networking solutions to enable commercial quantum computer scaling.
Deep TechHardwareQuantum ComputingCambridge, GB
Carmen Palacios-Berraquero(Founder)in
Co-investors7percent VenturesAhren Innovation CapitalAmadeus Capital PartnersExpeditionsIQ CapitalMartlet Capital+4 more
NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform.
BiotechDeep TechHardwareNew MaterialsNewcastle upon Tyne, GB
Co-investorsMartlet CapitalMaven Capital PartnersNorthstar Ventures
OctaiPipe offers a collaborative AI platform that optimises data centre cooling to cut cooling energy use by up to 30% and reduce total building energy costs.
AI & Machine LearningCleantechEnergyEnterprise SoftwareIoT
Co-investorsDouble DownMartlet CapitalMolten VenturesMomenta VenturesSuperSeed
Targeted radiopharmaceutical cancer treatment company
Oxford Space Systems designs and manufactures deployable antennas for satellites, focused on reducing mass and improving stowage efficiency and performance.
Deep TechHardwareSpace TechHarwell, GB
Co-investorsCambridge Angels groupFuture Planet CapitalLongwall Venture Partners LLPMartlet CapitalOxford Investment Opportunity NetworkOxford Investment Opportunity Network (OION)+4 more
Paragraf develops graphene-based electronic devices, including molecular sensors (electrolyte-gated field-effect transistors) for biosensing and chemical sensing, and Hall effect sensors for current, position, and magnetic field measurement at cryogenic temperatures.
Deep TechNew MaterialsSemiconductorsCambridgeshire, GB
Simon Thomas(Chief Executive Officer of the issuer.)in
Co-investorsAmadeus Capital PartnersBlack Opal VenturesCambridge Angels groupIn-Q-TelIQ CapitalMartlet Capital+4 more
PatientSource provides a cloud-based diagnostic testing module for healthcare settings that manages radiology, pathology, cardiology, and other clinical tests.
AI & Machine LearningCloud ComputingDigital HealthHealthtechSaaSCambridge, GB
Dr Michael Brooks(Founder)inDr Philip Ashworth(Founder)inLee Francis(Co-founder, Sales, Marketing and Partnerships Director)inPhil McSweeney(Executive Chair)in
Co-investorsCambridge Angels group
Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick.
BiotechDeep TechHealthtech
Co-investorsFuture Planet CapitalMartlet CapitalNorthern GritstoneOctopus VenturesUK Innovation & Science Seed Fund
Pervasid develops RFID technology for retail operations, providing real-time item-level inventory visibility in stores.
HardwareIoTRetail Tech
Co-investorsMartlet CapitalStanley Ventures
PharmEnable Therapeutics develops novel chemistry approaches and computational tools for drug discovery targeting therapeutically challenging molecules.
AI & Machine LearningBiotechDeep Tech
Dr Hannah Sore(Co-founder & Leadership)Dr Andreas Bender(Co-founder)
Plastometrex builds the PLX-Benchtop, a non-destructive mechanical testing machine that extracts metal stress-strain curves and strength properties (yield strength, UTS) from a small surface indentation using its PIP (Profilometry-based Indentation Plastometry) method.
Advanced ManufacturingDeep TechHardwareNew Materials
Co-investorsMartlet Capital
Plumis designs and manufactures intelligent water mist fire suppression systems for domestic and commercial use that detect fires earlier and deliver more effective outcomes than conventional sprinkler systems.
CleantechConstruction TechDeep TechHardwareIoTPropTech
William Makant(Co-founder and CEO)in
Co-investorsCambridge Angels group
Pointgrab develops computer vision sensors and real-time analytics software for workplace environments, enabling companies to gather and synthesize multiple data types for intelligent workspace applications.
AI & Machine LearningEnterprise SoftwareIoTPropTech
Amir Einav(CEO)in
Co-investorsEcoMachines VenturesABB Technology VenturesMitsubishi UFJ Capital
PoroTech develops MicroLED semiconductor materials and manufacturing processes for next-generation display and lighting applications.
Deep TechHardwareNew MaterialsSemiconductorsCambridge, GB
Dr. Tongtong Zhu(Co-founder)Dr. Yingjun Liu(Co-founder)Professor Rachel Oliver(Co-founder)
Co-investorsIQ Capital
Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people.
Digital HealthHealthtechMental Health
Dr. Melinda Rees(Chief Executive Officer)inRupert Hipwell(Chief Commercial Officer)inAlex Nancekievill(Chief Technology Officer)in
Co-investorsCambridge Angels groupMartlet Capital
SWARM Platform is a digital compliance management software for retrofit projects in the UK, serving housing associations, contractors, and local authorities.
CleantechConstruction TechGovTechNew MaterialsPropTechRoboticsSaaS
Co-investors2050 CapitalAdjuvoEcoMachines VenturesFoundamental
Qkine manufactures and supplies high-purity growth factors and cytokines for research and therapeutic applications, serving life sciences researchers and cell therapy developers.
BiotechDeep TechHealthtechNew MaterialsCambridge, GB
Dr Marko Hyvönen(CSO & Founder)
Co-investorsCambridge Angels groupMartlet CapitalOxford Investment Opportunity Network (OION)
QuantalX develops Delphi-MD, an FDA De Novo-cleared diagnostic device that directly measures brain network function using targeted magnetic stimulation and electrophysiological recording analyzed by proprietary algorithms.
AI & Machine LearningDigital HealthMedical Devices
Cellulose-based sustainable colorants for fashion, cosmetics, and packaging.
Co-investorsCambridge Angels groupMartlet CapitalSustainable VenturesAda Ventures
.jpeg){kind=logo}
RoboK offers SiteLens®, an AI computer vision platform that analyzes existing CCTV footage to detect workplace hazards, monitor PPE compliance, identify near misses, and generate safety KPI and compliance reports.
Advanced ManufacturingAI & Machine LearningLogistics & Supply Chain
Co-investorsAI SeedAmadeus Capital PartnersCambridge Angels groupMartlet Capital
SageTech Medical provides a circular economy system that captures waste volatile anaesthetic agents (sevoflurane, isoflurane, desflurane) from hospitals onto a reusable filter, then recovers and recycles them into greener pharmaceutical ingredients.
Circular EconomyHealthtechMedical Devices
Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research.
BiotechDeep TechMedical DevicesNew MaterialsSaaSCambridge, GB
Jeroen Verheyen(CEO and Co-Founder)inTarun Vemulkar(Co-founder & CTO)in
Co-investorsThe FSE GroupCambridge Capital GroupFound CapitalStart CodonMartlet CapitalParkwalk Advisors
Signaloid develops UxHw technology, a compute platform that propagates uncertainty by evaluating a distribution of inputs in a single program execution to produce distribution-based results.
AI & Machine LearningDeep TechHardwareSemiconductors
Phillip(Founder, CEO/CTO)
Co-investorsCambridge Angels groupIQ CapitalMartlet CapitalType One Ventures
Sofant develops satellite antenna terminals using proprietary RF MEMS technology for mobile connectivity applications including in-flight, maritime, and military communications.
Deep TechHardwareIoTSpace TechUK, GB
David Wither(CEO)in
BoardWill Whitehorn(Chairman)
Co-investorsKelvin CapitalSeraphim SpaceShibumi InternationalScottish Enterprise
Sorex Sensors develops film bulk acoustic resonator (FBAR) technology for sensor applications in semiconductor markets.
Deep TechHardwareHealthtechIoTSemiconductors
Michael LeGoff(Executive Chairman)
Co-investorsCambridge Angels groupMartlet Capital
Spotta builds IoT-based pest detection systems that automatically monitor for insects such as bed bugs, red palm weevil, and forestry pests.
AgTechAI & Machine LearningHardwareIoTCambridge, GB
Robert Fryers(Founder & CEO)inNeil D'Souza-Mathew(Founder & CTO)inRob Alner(COO)inMike Payne(Finance Director)
Co-investorsBayes Entrepreneurship FundCambridge Angels groupMartlet CapitalREMUS CapitalThe Yield Lab EuropeThe Yield Lab
Strolll uses augmented reality to deliver visual cueing and movement exercises for neurological rehabilitation, helping people with conditions such as Parkinson's and dementia-related gait problems.
Digital HealthHealthtechMedical Devices
Co-investorsFuture Planet CapitalIW CapitalKluz VenturesMartlet Capital
Techspert provides an expert-sourcing platform for market research teams in life sciences and healthcare, using in-house search technology to find vetted specialists for quantitative and qualitative studies.
AI & Machine LearningB2B MarketplacesHealthtechSaaS
Dave Holden(CEO & Co-Founder)Chris Musgrove(CFO)inJamie Beard(COO)
Co-investorsWestern Technology Investment
TransparentChoice provides a project portfolio prioritization system combining a criteria-based decision framework, a portfolio management platform, and expert PMO advisory support.
Enterprise SoftwareSaaS
Stuart Easton(Founder)in
Co-investorsCambridge Angels groupMartlet Capital
Tripism is a platform for corporate travel teams to communicate travel program information and engage with business travelers, replacing outdated travel intranets.
Enterprise SoftwareSaaSTravel & HospitalityCambridge, GB
Co-investorsMartlet Capital
Ventive designs and manufactures intelligent building service systems, including natural ventilation units that combine passive ventilation, heat recovery, and system intelligence to supply fresh air and regulate indoor temperatures.
CleantechConstruction TechHardware
Co-investorsRedstone
Wanda Health builds a data-driven virtual care system that turns cardiometabolic health data into predictive analytics, guided interventions, and outcome reporting.
AI & Machine LearningDigital HealthHealthtech
Xampla is a materials innovation company that develops Morro plant-based polymer materials as biodegradable, home-compostable alternatives to polluting plastics.
Circular EconomyDeep TechNew MaterialsCambridge, GB
Tuomas Knowles(Professor / Founder)Marc Rodriguez(CTO)inMarc Rodríguez Garciain
Co-investorsAmadeus Capital PartnersAvonmore DevelopmentsCambridge Angels groupEmerald Technology Ventures AgHorizons VenturesMartlet Capital+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cambridge Mechatronics - companyG-Tech MedicalVortex
Exits · 1
1 IPOsPDS Biotechnology Corp.NASDAQ: PDSB
Portfolio news
latest coverage across their companiesPDS Biotechnology Corp. · investing.com · Aug 11, 2026
Ventive · finance.yahoo.com · Aug 8, 2026
Glycotest · technical.ly · Aug 6, 2026
ProAxsis · respiratory-therapy.com · Jul 23, 2026
▶︎ CYTOVALE · funderintel.com · Jul 16, 2026
Cambridge Nutraceuticals · trysignalbase.com · Jun 16, 2026
Sofant · scottishfinancialnews.com · Dec 24, 2025
Wanda Health · emvcapital.com · Dec 10, 2025
Principals & officers · per Companies House
what is this? ⓘSecretary · since 2025
Director · British · since 2022
Director · British · since 2019
Director · British · since 2022
Director · British · since 2023
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| PDS Biotechnology Corp. | 10.6% | $1.30 | Feb 2020 | $710.7K |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has EMV Capital made?
- EMV Capital has 61 tracked investments, 1 of which have exited, including 2 dated in the last 24 months.
- What stage does EMV Capital invest at?
- EMV Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does EMV Capital focus on?
- EMV Capital focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Healthtech, Impact & Social Good, Robotics, Semiconductors.
- Where is EMV Capital located?
- EMV Capital is headquartered in London, GB.
- Does EMV Capital lead rounds?
- Yes, EMV Capital leads investment rounds.
- Who does EMV Capital co-invest with?
- EMV Capital most often shares deals with Martlet Capital, Cambridge Angels group, IQ Capital, among 79 tracked co-investors.
Media · Podcasts & interviews
featuring the teamInterview with EMV Capital CEO, Dr Ilian Iliev
Vox Markets · Ilian Iliev
Investing in high-tech industries – Dr Ilian Iliev, EMV Capital Evergreen EIS Fund
Wealth Club · Ilian Iliev · youtube.com
GrowthInvest - Adviser Hour: Interview with Dr Ilian Iliev - MD at EMV Capital
EMV Capital Perspectives · Ilian Iliev
Images
Similar investors
Simsan Ventures is a venture capital firm focused on backing overlooked and underrepresented founders, aiming to democratise access to entrepreneurship and support diverse emerging investors.
Supernova Invest is a venture capital firm providing expertise and patient capital to high-growth deeptech start-ups, helping scale them globally.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Safar Partners is an early-stage technology investment firm that backs startups spun out of leading research universities, primarily MIT, Harvard, and the University of Rochester.